当資料は、3M社（本社：米国ミネソタ州、NYSE:MMM）が2024年1月29日（現地時間）に発表した報道資料を抄訳したものです。

3Mは株式ではなく、現金による10億ドルの支払いを選択しました

本日、3Mはコンバット・アーム・イヤープラグの訴訟和解への請求人の参加率が、最終登録日である2024年3月25日までに和解合意で定められた参加基準の98%を超える見通しであることを発表しました。

2023年8月に発表された和解条件では、3Mは2023年から2029年にかけて、訴訟解決のために総額60億ドルを支払うことに合意し、その中には98％の参加基準を満たした場合に、総額のうち最大10億ドルを3Mの株式または現金で支払うオプションが含まれていました。3Mは株式ではなく、現金による10億ドルの支払いを選択しました。

和解に参加し、請求の放棄・棄却を選択した25万人以上の和解金を受けることができる請求人からの強力なサポートと、広域係属訴訟裁判所が命じた参加要件または訴訟要件を満たさない請求の継続的な棄却により、最終登録日までに訴訟請求の99%以上が解決される見込みです。

詳しくは3m-earplugsettlement.comをご覧ください。

Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) risks related to certain fluorochemicals, including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio; (4) risks related to the proposed class-action settlement ("PWS Settlement") to resolve claims by public water systems in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2022 and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company's Health Care business; and (16) matters relating to Combat Arms Earplugs ("CAE"), including those relating to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates ("Aearo Entities") and/or 3M ("CAE Settlement"), including, but not limited to, whether the anticipated participation by plaintiffs in the CAE Settlement will be achieved, whether the number of plaintiffs that participate in the CAE Settlement will meet current expectations or will fall below the level that would permit 3M to terminate the CAE Settlement (and whether 3M will elect to terminate the CAE Settlement if this occurs), whether there will be a significant number of future claims by plaintiffs that decline to participate in the CAE Settlement, whether the CAE Settlement is appealed or challenged, the filing of additional, or the outcome of any other pending or future, litigation relating to the products that are the subject of the CAE Settlement, or changes in related laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

【3Mについて】
3M(本社：米国ミネソタ州)は、サイエンス（科学）が明るい未来を創造すると信じています。人びと、アイデア、サイエンスの力を解き放つことによりさらなる可能性を模索し、世界中の社員がお客様、地域社会、そして地球の課題を解決するために取り組んでいます。人びとの暮らしを豊かにし、「これから」を創り出すための3Mの活動は3M.com/newsをご覧ください。3Mジャパングループについてはnews.3mcompany.jp/news-centerをご覧ください。

3Mは3M社の商標です。
ニュースリリースに掲載している内容は発表時点の情報です。
最新の情報とは異なる場合がございますので、あらかじめご了承ください。